Neurological Surgery 脳神経外科51巻4号

2023年07月発行

特集 下垂体腫瘍診療の新フェーズ—変革期の疫学・診断・治療における必須知識 Ⅳ 下垂体腫瘍の治療

下垂体腫瘍の放射線治療—最新の知見から

著者： 長谷川洋敬¹

所属機関： ¹東京大学医学部脳神経外科

ページ範囲：P.716 - P.724

Point
・放射線治療モダリティは多種多様であり，状況に応じて適切に選択する必要がある．
・下垂体腫瘍では基本的に手術（病理診断）・薬物治療が優先され，再発・残存例に放射線治療が行われることが多い．
・機能を落とさないように配慮した手術に放射線治療を加えることで，患者アウトカムを最大化できる可能性がある．

参考文献

1）Minniti G, et al：Management of nonfunctioning pituitary tumors：radiotherapy. Pituitary 21：154-161, 2018

2）Milano MT, et al：Single- and multi-fraction stereotactic radiosurgery dose tolerances of the optic pathways. Int J Radiat Oncol Biol Phys 110：87-99, 2021

3）Leavitt JA, et al：Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 87：524-527, 2013

4）Losa M, et al：Role of radiosurgery in the treatment of Cushing's disease. J Neuroendocrinol 34：e13134, 2022　doi：10.1111/jne.13134

5）Murphy ES, et al. Review of cranial radiotherapy-induced vasculopathy. J Neurooncol 122：421-429, 2015

6）Pikis S, et al：Internal carotid artery stenosis and risk of cerebrovascular ischemia following stereotactic radiosurgery for recurrent or residual pituitary adenomas. Pituitary 24：574-581, 2021

7）Graffeo CS, et al：Risk of internal carotid artery stenosis or occlusion after single-fraction radiosurgery for benign parasellar tumors. J Neurosurg 133：1388-1395, 2019

8）Flickinger JC, et al：Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 63：2404-2408, 1989

9）Darzy KH, Shalet SM：Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8：203-211, 2005

10）Vakilian S, et al：Examination of the dose-effect relationship of radiation-induced hypopituitarism：results of a case-control study. Adv Radiat Oncol 6：100693, 2021　doi：10.1016/j.adro.2021.100693

11）Pomeraniec IJ, et al：Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function：an international multicenter study. J Neurosurg 136：813-821, 2022

12）Minniti G, et al：Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma：update after an additional 10 years. J Clin Endocrinol Metab 90：800-804, 2005

13）McCord MW, et al：Radiotherapy for pituitary adenoma：long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39：437-444, 1997

14）al-Mefty O, et al：The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73：502-512, 1990

15）Rowe J, et al：Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60：60-65；discussion 65-66, 2007

16）Tooze A, Sheehan JP：Neurocognitive changes in pituitary adenoma patients after Gamma Knife radiosurgery. J Neurosurg 129：55-62, 2018

17）Sheehan JP, et al：Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas：a multicenter study. J Neurosurg 119：446-456, 2013

18）Kong DS, et al：The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas：long-term results of 125 consecutive patients treated in a single institution. Cancer 110：854-860, 2007

19）Pollock BE, et al：Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas：factors associated with endocrine normalization. J Neurosurg 97：525-530, 2002

20）Hung YC, et al：The benefit and risk of stereotactic radiosurgery for prolactinomas：an international multicenter cohort study. J Neurosurg 133：717-726, 2019

21）Ježková J, et al：Role of gamma knife radiosurgery in the treatment of prolactinomas. Pituitary 22：411-421, 2019

22）Sheehan JP, et al：Results of gamma knife surgery for Cushing's disease. J Neurosurg 119：1486-1492, 2013

23）Ding D, et al：Stereotactic radiosurgery for acromegaly：an international multicenter retrospective cohort study. Neurosurgery 84：717-725, 2019

24）Lee CC, et al：Stereotactic radiosurgery for acromegaly：outcomes by adenoma subtype. Pituitary 18：326-334, 2015

25）Cohen-Inbar O, et al：Gamma Knife radiosurgery for medically and surgically refractory prolactinomas：long-term results. Pituitary 18：820-830, 2015

26）Tritos NA, Biller BM：Update on radiation therapy in patients with Cushing's disease. Pituitary 18：263-268, 2015

27）Mouslech Z, et al：TSH-secreting pituitary adenomas treated by gamma knife radiosurgery：our case experience and a review of the literature. Hormones（Athens）15：122-128, 2016

28）Müller HL, et al：Craniopharyngioma. Nat Rev Dis Primers 5：75, 2019　doi：10.1038/s41572-019-0125-9

29）Merchant TE, et al：Endocrine outcomes after limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma：long-term results from the RT1 protocol. Neuro Oncol 24：2210-2220, 2022

30）Minniti G, et al：The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma. Neurosurg Rev 32：125-132；discussion 132, 2009

31）Iwata H, et al：Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma. J Neurooncol 106：571-577, 2012

32）Hill TK, et al：Patterns of care in pediatric craniopharyngioma：outcomes following definitive radiotherapy. Anticancer Res 39：803-807, 2019

33）Young M, et al：Radiotherapy alone for pediatric patients with craniopharyngioma. J Neurooncol 156：195-204, 2022

34）Merchant TE, et al：Pediatric craniopharyngioma：the effect of visual deficits and hormone deficiencies on long-term cognitive outcomes after conformal photon radiation therapy. Int J Radiat Oncol Biol Phys 115：581-591, 2023

35）Lamiman K, et al：A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus 41：E15, 2016　doi：10.3171/2016.9.FOCUS16298

36）Iannalfi A, et al：Corrigendum to：Proton and carbon ion radiotherapy in skull base chordomas：a prospective study based on a dual particle and a patient-customized treatment strategy. Neuro Oncol 24：1402-1403, 2022

37）McDonald MW, et al：Dose-volume relationships associated with temporal lobe radiation necrosis after skull base proton beam therapy. Int J Radiat Oncol Biol Phys 91：261-267, 2015

38）Pikis S, et al：Stereotactic radiosurgery for intracranial chordomas：an international multiinstitutional study. J Neurosurg 137：977-984, 2022

39）Kano H, et al：Skull base chondrosarcoma radiosurgery：report of the North American Gamma Knife Consortium. J Neurosurg 123：1268-1275, 2015

40）Shinya Y, et al：High dose radiosurgery targeting the primary tumor sites contributes to survival in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 113：582-587, 2022

41）Gendreau J, et al：Radiotherapy after gross total resection of skull base chordoma：a surveillance, epidemiology, and end results database analysis of survival outcomes. World Neurosurg 172：e68-e76, 2023　doi：10.1016/j.wneu.2022.12.012

42）Hasegawa H, et al：Role of endoscopic transnasal surgery for skull base chondrosarcoma：a retrospective analysis of 19 cases at a single institution. J Neurosurg 128：1438-1447, 2018

43）Hasegawa H, et al：Long-term outcomes of grade I/II skull base chondrosarcoma：an insight into the role of surgery and upfront radiotherapy. J Neurooncol 153：273-281, 2021

44）Merna C, et al：Determinants of survival in skull base chondrosarcoma：a national cancer database study. World Neurosurg 158：e766-e777, 2022　doi：10.1016/j.wneu.2021.11.066

45）Kawashima M, et al：Outcomes of Gamma Knife radiosurgery for skull base chondrosarcomas：a multi-institutional retrospective study. J Neurosurg 137：969-976, 2022

46）Koga T, et al：Treatment with high marginal dose is mandatory to achieve long-term control of skull base chordomas and chondrosarcomas by means of stereotactic radiosurgery. J Neurooncol 98：233-238, 2010

47）Riva G, et al：Particle radiotherapy for skull base chondrosarcoma：a clinical series from Italian National Center for Oncological Hadrontherapy. Cancers（Basel）13：4423, 2021　doi：10.3390/cancers13174423

48）Parzen JS, et al：Proton therapy for skull-base chordomas and chondrosarcomas：initial results from the Beaumont Proton Therapy Center. Cureus 13：e15278, 2021　doi：10.7759/cureus.15278

49）Lu VM, et al：Carbon ion radiotherapy for skull base chordomas and chondrosarcomas：a systematic review and meta-analysis of local control, survival, and toxicity outcomes. J Neurooncol 147：503-513, 2020

50）Leroy HA, et al：Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma：a systematic review and meta-analysis. Acta Neurochir（Wien）160：2367-2378, 2018

51）Lee CC, et al：Gamma Knife radiosurgery for hemangioma of the cavernous sinus. J Neurosurg 126：1498-1505, 2017

52）Anqi X, et al：Cavernous sinus cavernous hemangioma：imaging features and therapeutic effect of Gamma Knife radiosurgery. Clin Neurol Neurosurg 127：59-64, 2014

53）Yamamoto M, et al：Gamma Knife radiosurgery for hemangiomas of the cavernous sinus：a seven-institute study in Japan. J Neurosurg 112：772-779, 2010

54）Chou CW, et al：Gamma knife surgery for cavernous hemangiomas in the cavernous sinus. Neurosurgery 67：611-616；discussion 616, 2010